EcoDrugPlus

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSCAFG00020006156
Gene Symbol: GRM4
3 Cross references
266 Possible Orthologues:

Glutamate Metabotropic Receptor 5

Ensembl ID : ENSCAFG00020016867
Gene Symbol: GRM5
3 Cross references
278 Possible Orthologues:

Glutaminase

Ensembl ID : ENSCAFG00020005567
Gene Symbol: GLS
3 Cross references
306 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSCAFG00020014351
Gene Symbol: GSK3A
3 Cross references
259 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSCAFG00020006540
Gene Symbol: GSK3B
3 Cross references
244 Possible Orthologues:

Gonadotropin Releasing Hormone Receptor

Ensembl ID : ENSCAFG00020027129
Gene Symbol: GNRHR
3 Cross references
242 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSCAFG00020004373
Gene Symbol: GHRHR
3 Cross references
193 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSCAFG00020004605
Gene Symbol: GHSR
3 Cross references
211 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSCAFG00020002511
Gene Symbol: GUCY1A1
3 Cross references
203 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSCAFG00020008933
Gene Symbol: GUCY1A2
3 Cross references
203 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSCAFG00020002515
Gene Symbol: GUCY1B1
3 Cross references
211 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class A Member 1

Ensembl ID : ENSCAFG00020009107
Gene Symbol: HSP90AA1
3 Cross references
263 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).